VERACYTE, INC. Stock-Based Compensation
VERACYTE, INC. (VCYT) reported Stock-Based Compensation of $26.85 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-07-31
- VERACYTE, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $14.09M, a 28.23% increase year-over-year.
- VERACYTE, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $12.76M, a 16.45% increase year-over-year.
- VERACYTE, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $10.90M, a 13.21% increase year-over-year.
- VERACYTE, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $10.76M, a 22.98% increase year-over-year.
- VERACYTE, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $43.60M, a 20.28% increase from fiscal 2024.
- VERACYTE, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $36.25M, a 9.38% increase from fiscal 2023.
- VERACYTE, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $33.14M, a 23.97% increase from fiscal 2022.
- VERACYTE, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $26.73M, a 18.72% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $14.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | $26.85M 10-Q · filed 2026-07-31 | $37.75M derived: sum of 3 quarters · filed 2026-07-31 | $48.51M derived: sum of 4 quarters · filed 2026-07-31 |
| 2026-03-31 | $12.76M 10-Q · filed 2026-05-06 | $23.66M derived: sum of 2 quarters · filed 2026-05-06 | $34.42M derived: sum of 3 quarters · filed 2026-05-06 | $45.40M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-12-31 | $10.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $21.66M derived: sum of 2 quarters · filed 2026-02-26 | $32.64M derived: sum of 3 quarters · filed 2026-07-31 | $43.60M 10-K · filed 2026-02-26 |
| 2025-09-30 | $10.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $21.74M derived: sum of 2 quarters · filed 2026-07-31 | $32.70M 10-Q · filed 2025-11-05 | $42.33M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-06-30 | $10.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | $21.94M 10-Q · filed 2026-07-31 | $31.57M derived: sum of 3 quarters · filed 2026-07-31 | $40.32M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-03-31 | $10.96M 10-Q · filed 2026-05-06 | $20.59M derived: sum of 2 quarters · filed 2026-05-06 | $29.33M derived: sum of 3 quarters · filed 2026-05-06 | $39.19M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $9.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $18.38M derived: sum of 2 quarters · filed 2026-02-26 | $28.23M derived: sum of 3 quarters · filed 2026-02-26 | $36.25M 10-K · filed 2026-02-26 |
| 2024-09-30 | $8.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $18.60M derived: sum of 2 quarters · filed 2025-11-05 | $26.62M 10-Q · filed 2025-11-05 | $34.13M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $9.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $17.87M 10-Q · filed 2025-08-07 | $25.39M derived: sum of 3 quarters · filed 2026-02-26 | $32.65M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $8.02M 10-Q · filed 2025-05-08 | $15.53M derived: sum of 2 quarters · filed 2026-02-26 | $22.79M derived: sum of 3 quarters · filed 2026-02-26 | $33.17M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $7.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $14.78M derived: sum of 2 quarters · filed 2026-02-26 | $25.16M derived: sum of 3 quarters · filed 2026-02-26 | $33.14M 10-K · filed 2026-02-26 |
| 2023-09-30 | $7.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $17.64M derived: sum of 2 quarters · filed 2024-11-07 | $25.63M 10-Q · filed 2024-11-07 | $32.50M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $10.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $18.37M 10-Q · filed 2024-08-07 | $25.23M derived: sum of 3 quarters · filed 2025-02-28 | $32.52M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $7.99M 10-Q · filed 2024-05-08 | $14.85M derived: sum of 2 quarters · filed 2025-02-28 | $22.14M derived: sum of 3 quarters · filed 2025-02-28 | $28.07M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $6.87M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $14.15M derived: sum of 2 quarters · filed 2025-02-28 | $20.09M derived: sum of 3 quarters · filed 2025-02-28 | $26.73M 10-K · filed 2025-02-28 |
| 2022-09-30 | $7.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $13.22M derived: sum of 2 quarters · filed 2023-11-08 | $19.87M 10-Q · filed 2023-11-08 | $26.60M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $5.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $12.58M 10-Q · filed 2023-08-09 | $19.32M derived: sum of 3 quarters · filed 2024-02-29 | $27.18M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $6.64M 10-Q · filed 2023-05-05 | $13.38M derived: sum of 2 quarters · filed 2024-02-29 | $21.25M derived: sum of 3 quarters · filed 2024-02-29 | $25.31M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $6.73M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $14.60M derived: sum of 2 quarters · filed 2024-02-29 | $18.66M derived: sum of 3 quarters · filed 2024-02-29 | $22.52M 10-K · filed 2024-02-29 |
| 2021-09-30 | $7.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $11.93M derived: sum of 2 quarters · filed 2022-11-03 | $15.79M 10-Q · filed 2022-11-03 | $19.43M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $4.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $7.92M 10-Q · filed 2022-08-03 | $11.56M derived: sum of 3 quarters · filed 2023-03-01 | $14.65M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $3.85M 10-Q · filed 2022-05-04 | $7.50M derived: sum of 2 quarters · filed 2023-03-01 | $10.59M derived: sum of 3 quarters · filed 2023-03-01 | $13.95M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $3.64M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $6.73M derived: sum of 2 quarters · filed 2023-03-01 | $10.09M derived: sum of 3 quarters · filed 2023-03-01 | $12.99M 10-K · filed 2023-03-01 |
| 2020-09-30 | $3.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $6.45M derived: sum of 2 quarters · filed 2021-11-09 | $9.35M 10-Q · filed 2021-11-09 | $12.20M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $3.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $6.26M 10-Q · filed 2021-07-29 | $9.11M derived: sum of 3 quarters · filed 2022-02-28 | $11.75M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $2.90M 10-Q · filed 2021-05-10 | $5.75M derived: sum of 2 quarters · filed 2022-02-28 | $8.39M derived: sum of 3 quarters · filed 2022-02-28 | $10.95M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $2.84M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $5.48M derived: sum of 2 quarters · filed 2022-02-28 | $8.05M derived: sum of 3 quarters · filed 2022-02-28 | $9.81M 10-K · filed 2022-02-28 |
| 2019-09-30 | $2.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $5.21M derived: sum of 2 quarters · filed 2020-11-02 | $6.96M 10-Q · filed 2020-11-02 | $8.50M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-06-30 | $2.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $4.33M 10-Q · filed 2020-07-30 | $5.86M derived: sum of 3 quarters · filed 2021-02-22 | $7.38M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-03-31 | $1.76M 10-Q · filed 2020-05-06 | $3.29M derived: sum of 2 quarters · filed 2021-02-22 | $4.81M derived: sum of 3 quarters · filed 2021-02-22 | $6.54M derived: sum of 4 quarters · filed 2021-02-22 |
| 2018-12-31 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $3.05M derived: sum of 2 quarters · filed 2021-02-22 | $4.78M derived: sum of 3 quarters · filed 2021-02-22 | $5.96M 10-K · filed 2021-02-22 |
| 2018-09-30 | $1.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-22 | $3.25M derived: sum of 2 quarters · filed 2019-10-22 | $4.42M 10-Q · filed 2019-10-22 | $6.22M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $1.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-30 | $2.91M 10-Q · filed 2019-07-30 | $4.70M derived: sum of 3 quarters · filed 2020-02-25 | $6.31M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $1.18M 10-Q · filed 2019-04-30 | $2.97M derived: sum of 2 quarters · filed 2020-02-25 | $4.58M derived: sum of 3 quarters · filed 2020-02-25 | $6.22M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $3.40M derived: sum of 2 quarters · filed 2020-02-25 | $5.04M derived: sum of 3 quarters · filed 2020-02-25 | $6.62M 10-K · filed 2020-02-25 |
| 2017-09-30 | $1.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-29 | $3.25M derived: sum of 2 quarters · filed 2018-10-29 | $4.83M 10-Q · filed 2018-10-29 | $6.46M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-06-30 | $1.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-23 | $3.21M 10-Q · filed 2018-07-23 | $4.85M derived: sum of 3 quarters · filed 2019-02-25 | $6.42M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-03-31 | $1.57M 10-Q · filed 2018-05-01 | $3.21M derived: sum of 2 quarters · filed 2019-02-25 | $4.78M derived: sum of 3 quarters · filed 2019-02-25 | $6.45M derived: sum of 4 quarters · filed 2019-02-25 |
| 2016-12-31 | $1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $3.21M derived: sum of 2 quarters · filed 2019-02-25 | $4.88M derived: sum of 3 quarters · filed 2019-02-25 | $6.38M 10-K · filed 2019-02-25 |
| 2016-09-30 | $1.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $3.25M derived: sum of 2 quarters · filed 2017-11-07 | $4.75M 10-Q · filed 2017-11-07 | $6.16M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $1.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-31 | $3.17M 10-Q · filed 2017-07-31 | $4.59M derived: sum of 3 quarters · filed 2018-02-27 | $6.06M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $1.50M 10-Q · filed 2017-05-03 | $2.91M derived: sum of 2 quarters · filed 2018-02-27 | $4.39M derived: sum of 3 quarters · filed 2018-02-27 | $5.88M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $2.89M derived: sum of 2 quarters · filed 2018-02-27 | $4.38M derived: sum of 3 quarters · filed 2018-02-27 | $5.60M 10-K · filed 2018-02-27 |
| 2015-09-30 | $1.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $2.96M derived: sum of 2 quarters · filed 2016-11-03 | $4.19M 10-Q · filed 2016-11-03 | $5.33M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $1.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $2.71M 10-Q · filed 2016-08-03 | $3.86M derived: sum of 3 quarters · filed 2017-03-01 | $4.89M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $1.22M 10-Q · filed 2016-05-05 | $2.37M derived: sum of 2 quarters · filed 2017-03-01 | $3.40M derived: sum of 3 quarters · filed 2017-03-01 | |
| 2014-12-31 | $1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $2.18M derived: sum of 2 quarters · filed 2017-03-01 | $3.55M 10-K · filed 2017-03-01 | |
| 2014-09-30 | $1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $2.40M 10-Q · filed 2015-11-05 | ||
| 2014-06-30 | $1.37M 10-Q · filed 2015-08-13 | |||
| 2013-12-31 | $1.25M 10-K · filed 2016-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |